Kopran - Quaterly Results

11 Nov 2022 Evaluate
Revenue reduced marginally to stand at Rs. 536.23 millions during the quarter ended September 2022. The figure stood at Rs. 562.25 millions during the year-ago period.The Net Profit of the company vaulted to 373.70% to Rs. 178.87  millions from Rs. 37.76 millions in the previous quarter.OP of the company witnessed a marginal growth to 206.43 millions from 65.72 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 536.23 562.25 -4.63 1248.03 854.45 46.06 2045.20 2228.33 -8.22
Other Income 147.38 19.72 647.36 149.11 43.23 244.92 80.27 104.14 -22.92
PBIDT 206.43 65.72 214.11 272.99 94.45 189.03 234.40 406.14 -42.29
Interest 6.13 5.26 16.54 11.08 11.81 -6.18 29.53 38.07 -22.43
PBDT 200.30 60.46 231.29 261.91 82.64 216.93 204.87 368.07 -44.34
Depreciation 11.23 10.88 3.22 22.04 21.65 1.80 43.23 41.03 5.36
PBT 189.07 49.58 281.34 239.87 60.99 293.29 161.64 327.04 -50.57
TAX 10.20 11.82 -13.71 22.96 14.52 58.13 44.20 92.33 -52.13
Deferred Tax -1.74 3.05 -157.05 -2.76 3.76 -173.40 6.73 34.76 -80.64
PAT 178.87 37.76 373.70 216.91 46.47 366.77 117.44 234.71 -49.96
Equity 482.11 432.52 11.47 482.11 432.52 11.47 482.12 432.52 11.47
PBIDTM(%) 38.50 11.69 229.35 21.87 11.05 97.88 11.46 18.23 -37.12

Kopran Share Price

216.30 -4.70 (-2.13%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.